COVID-19 Impact on Global Esophageal Cancer Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: CFD68A45C1ADEN
QYResearch

Abstracts

This report focuses on the global Esophageal Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Esophageal Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• Sanofi
• ...

Market segment by Type, the product can be split into

• Fluorouracil
• Cisplatin
• Docetaxel
• Carboplatin
• Others

Market segment by Application, split into

• Targeted Therapy
• Chemotherapy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Esophageal Cancer Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Esophageal Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Esophageal Cancer Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Esophageal Cancer Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Esophageal Cancer Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fluorouracil
  1.4.3 Cisplatin
  1.4.4 Docetaxel
  1.4.5 Carboplatin
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Esophageal Cancer Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Targeted Therapy
  1.5.3 Chemotherapy
1.6 Coronavirus Disease 2019 (Covid-19): Esophageal Cancer Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Esophageal Cancer Drugs Industry
    1.6.1.1 Esophageal Cancer Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Esophageal Cancer Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Esophageal Cancer Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Esophageal Cancer Drugs Market Perspective (2015-2026)
2.2 Esophageal Cancer Drugs Growth Trends by Regions
  2.2.1 Esophageal Cancer Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Esophageal Cancer Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Esophageal Cancer Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Esophageal Cancer Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Esophageal Cancer Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Esophageal Cancer Drugs Players by Market Size
  3.1.1 Global Top Esophageal Cancer Drugs Players by Revenue (2015-2020)
  3.1.2 Global Esophageal Cancer Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Esophageal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Esophageal Cancer Drugs Market Concentration Ratio
  3.2.1 Global Esophageal Cancer Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Esophageal Cancer Drugs Revenue in 2019
3.3 Esophageal Cancer Drugs Key Players Head office and Area Served
3.4 Key Players Esophageal Cancer Drugs Product Solution and Service
3.5 Date of Enter into Esophageal Cancer Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Esophageal Cancer Drugs Historic Market Size by Type (2015-2020)
4.2 Global Esophageal Cancer Drugs Forecasted Market Size by Type (2021-2026)

5 ESOPHAGEAL CANCER DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Esophageal Cancer Drugs Market Size by Application (2015-2020)
5.2 Global Esophageal Cancer Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Esophageal Cancer Drugs Market Size (2015-2020)
6.2 Esophageal Cancer Drugs Key Players in North America (2019-2020)
6.3 North America Esophageal Cancer Drugs Market Size by Type (2015-2020)
6.4 North America Esophageal Cancer Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Esophageal Cancer Drugs Market Size (2015-2020)
7.2 Esophageal Cancer Drugs Key Players in Europe (2019-2020)
7.3 Europe Esophageal Cancer Drugs Market Size by Type (2015-2020)
7.4 Europe Esophageal Cancer Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Esophageal Cancer Drugs Market Size (2015-2020)
8.2 Esophageal Cancer Drugs Key Players in China (2019-2020)
8.3 China Esophageal Cancer Drugs Market Size by Type (2015-2020)
8.4 China Esophageal Cancer Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Esophageal Cancer Drugs Market Size (2015-2020)
9.2 Esophageal Cancer Drugs Key Players in Japan (2019-2020)
9.3 Japan Esophageal Cancer Drugs Market Size by Type (2015-2020)
9.4 Japan Esophageal Cancer Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Esophageal Cancer Drugs Market Size (2015-2020)
10.2 Esophageal Cancer Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Esophageal Cancer Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Esophageal Cancer Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Esophageal Cancer Drugs Market Size (2015-2020)
11.2 Esophageal Cancer Drugs Key Players in India (2019-2020)
11.3 India Esophageal Cancer Drugs Market Size by Type (2015-2020)
11.4 India Esophageal Cancer Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Esophageal Cancer Drugs Market Size (2015-2020)
12.2 Esophageal Cancer Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Esophageal Cancer Drugs Market Size by Type (2015-2020)
12.4 Central & South America Esophageal Cancer Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bristol-Myers Squibb Company
  13.1.1 Bristol-Myers Squibb Company Company Details
  13.1.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Introduction
  13.1.4 Bristol-Myers Squibb Company Revenue in Esophageal Cancer Drugs Business (2015-2020))
  13.1.5 Bristol-Myers Squibb Company Recent Development
13.2 Eli Lilly and Company
  13.2.1 Eli Lilly and Company Company Details
  13.2.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.2.3 Eli Lilly and Company Esophageal Cancer Drugs Introduction
  13.2.4 Eli Lilly and Company Revenue in Esophageal Cancer Drugs Business (2015-2020)
  13.2.5 Eli Lilly and Company Recent Development
13.3 F. Hoffmann-La Roche Ltd
  13.3.1 F. Hoffmann-La Roche Ltd Company Details
  13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  13.3.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Introduction
  13.3.4 F. Hoffmann-La Roche Ltd Revenue in Esophageal Cancer Drugs Business (2015-2020)
  13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Merck & Co., Inc.
  13.4.1 Merck & Co., Inc. Company Details
  13.4.2 Merck & Co., Inc. Business Overview and Its Total Revenue
  13.4.3 Merck & Co., Inc. Esophageal Cancer Drugs Introduction
  13.4.4 Merck & Co., Inc. Revenue in Esophageal Cancer Drugs Business (2015-2020)
  13.4.5 Merck & Co., Inc. Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Esophageal Cancer Drugs Introduction
  13.5.4 Sanofi Revenue in Esophageal Cancer Drugs Business (2015-2020)
  13.5.5 Sanofi Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Esophageal Cancer Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Esophageal Cancer Drugs Revenue
Table 3. Ranking of Global Top Esophageal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Esophageal Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fluorouracil
Table 6. Key Players of Cisplatin
Table 7. Key Players of Docetaxel
Table 8. Key Players of Carboplatin
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Esophageal Cancer Drugs Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Esophageal Cancer Drugs Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Esophageal Cancer Drugs Players to Combat Covid-19 Impact
Table 15. Global Esophageal Cancer Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Esophageal Cancer Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Esophageal Cancer Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Esophageal Cancer Drugs Market Share by Regions (2015-2020)
Table 19. Global Esophageal Cancer Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Esophageal Cancer Drugs Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Esophageal Cancer Drugs Market Growth Strategy
Table 25. Main Points Interviewed from Key Esophageal Cancer Drugs Players
Table 26. Global Esophageal Cancer Drugs Revenue by Players (2015-2020) (Million US$)
Table 27. Global Esophageal Cancer Drugs Market Share by Players (2015-2020)
Table 28. Global Top Esophageal Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Drugs as of 2019)
Table 29. Global Esophageal Cancer Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Esophageal Cancer Drugs Product Solution and Service
Table 32. Date of Enter into Esophageal Cancer Drugs Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. Global Esophageal Cancer Drugs Market Size Share by Type (2015-2020)
Table 36. Global Esophageal Cancer Drugs Revenue Market Share by Type (2021-2026)
Table 37. Global Esophageal Cancer Drugs Market Size Share by Application (2015-2020)
Table 38. Global Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. Global Esophageal Cancer Drugs Market Size Share by Application (2021-2026)
Table 40. North America Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 42. North America Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. North America Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 44. North America Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. North America Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 46. Europe Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 48. Europe Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 50. Europe Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 52. China Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 53. China Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 54. China Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. China Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 56. China Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. China Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 58. Japan Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 60. Japan Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 62. Japan Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 66. Southeast Asia Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 68. Southeast Asia Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 70. India Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 71. India Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 72. India Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. India Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 74. India Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. India Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Esophageal Cancer Drugs Market Share (2019-2020)
Table 78. Central & South America Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Esophageal Cancer Drugs Market Share by Type (2015-2020)
Table 80. Central & South America Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Esophageal Cancer Drugs Market Share by Application (2015-2020)
Table 82. Bristol-Myers Squibb Company Company Details
Table 83. Bristol-Myers Squibb Company Business Overview
Table 84. Bristol-Myers Squibb Company Product
Table 85. Bristol-Myers Squibb Company Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$)
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Eli Lilly and Company Company Details
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Product
Table 90. Eli Lilly and Company Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$)
Table 91. Eli Lilly and Company Recent Development
Table 92. F. Hoffmann-La Roche Ltd Company Details
Table 93. F. Hoffmann-La Roche Ltd Business Overview
Table 94. F. Hoffmann-La Roche Ltd Product
Table 95. F. Hoffmann-La Roche Ltd Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$)
Table 96. F. Hoffmann-La Roche Ltd Recent Development
Table 97. Merck & Co., Inc. Company Details
Table 98. Merck & Co., Inc. Business Overview
Table 99. Merck & Co., Inc. Product
Table 100. Merck & Co., Inc. Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$)
Table 101. Merck & Co., Inc. Recent Development
Table 102. Sanofi Company Details
Table 103. Sanofi Business Overview
Table 104. Sanofi Product
Table 105. Sanofi Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$)
Table 106. Sanofi Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Esophageal Cancer Drugs Market Share by Type: 2020 VS 2026
Figure 2. Fluorouracil Features
Figure 3. Cisplatin Features
Figure 4. Docetaxel Features
Figure 5. Carboplatin Features
Figure 6. Others Features
Figure 7. Global Esophageal Cancer Drugs Market Share by Application: 2020 VS 2026
Figure 8. Targeted Therapy Case Studies
Figure 9. Chemotherapy Case Studies
Figure 10. Esophageal Cancer Drugs Report Years Considered
Figure 11. Global Esophageal Cancer Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Esophageal Cancer Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Esophageal Cancer Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Esophageal Cancer Drugs Market Share by Players in 2019
Figure 16. Global Top Esophageal Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Esophageal Cancer Drugs Revenue in 2019
Figure 18. North America Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bristol-Myers Squibb Company Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020)
Figure 27. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eli Lilly and Company Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020)
Figure 29. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020)
Figure 31. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck & Co., Inc. Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020)
Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed